Updates

Craneware

August 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Craneware went up over £2 to an all-time record of 2412p after it said that for the year to end June it expects to report revenues +16% and a 20% jump in adjusted EBITDA. Net cash stands at US$53m.The year has seen renewals running at 100% and a 100% increase year-on-year in new sales. This includes a further significant new contract with a large hospital network in the Eastern US for its Pharmacy ChargeLink solution. From October, Craneware's solution will be rolled out to the 12 facilities across the Network. This contract is expected to deliver US$6m of revenue over its initial 5-year term. Investec forecasts eps of 56.7 cents for the year ended June with 64.4 cents this year.A main write up in Nov ‘15 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Swallowfield

Dunelm

Craneware (September 2024)

Craneware - Growing pipeline of opportunities (October 2023)

Craneware (July 2019)

Craneware - Two significant new contracts (March 2018)

Craneware - Gain since main profile: 154% (February 2018)

Craneware - Bullet proof business (October 2016)

Craneware (August 2016)

Craneware - Big beneficiary of Obamacare (November 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X